Making hay while the Sun shines
Success hinges on the company getting its GMP right and surviving the glare of regulatory scrutiny
Author
Intent right, but implementation is key
Finance Minister Arun Jaitley’s first Union Budget had nothing special for the pharmaceutical industry
Govt to release policy to improve bulk drug capacity: Subburaj
Other topics at the ASSOCHAM Pharma Summit included changes in drug pricing, the impending revision of NLEM-2011, and amendments…
Policy pinings
As in previous years, we mark this Women's Day with a cover story section devoted to women's health issue
The politics of IPR policy
The draft National IPR policy, unveiled last December by the Department of Industrial Policy & Promotion (DIPP), has already…
‘The health industry as a whole has a positive future’
In a free-wheeling conversation with Viveka Roychowdhury, Patrick Figgis, Global Health Leader, PwC and Sujay Shetty,…
Panacea Biotec: A Turnaround Story
After three consecutive years of negative EBITDA, Panacea Biotec looks set to script a successful revival. Dr Rajesh Jain, Joint…
The bigger picture vs the nitty-gritty
While we are urged to look beyond the sticky issues, one cannot overlook the final impact of decisions on India's IPR policy
Pet vs Glass: Who will blink first?
The Health Ministry has predictably stirred a hornet's nest with its diktat to replace PET with glass packaging for certain…
Could a surgeon become DCG(I)?
CDSCO's planned 'harmonisation of recruitment rules' is sure to resurrect this debate